Patents by Inventor Christopher Gibson

Christopher Gibson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12575735
    Abstract: An imaging device includes a body having a first end portion configured to be held in a user's hand and a second end portion configured to direct light onto a surgical margin. The device includes at least one excitation light source configured to excite autofluorescence emissions of tissue cells and fluorescence emissions of induced porphyrins in tissue cells of the surgical margin. A white light source is configured to illuminate the surgical margin during white light imaging of the surgical margin. The device includes an imaging sensor, a first optical filter configured to permit passage of autofluorescence emissions of tissue cells and fluorescence emissions of the induced porphyrins in tissue cells to the imaging sensor, and a second optical filter configured to permit passage of white light emissions of tissues in the surgical margin to the imaging sensor. Systems and methods relate to imaging devices.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: March 17, 2026
    Assignees: SBI ALAPHARMA CANADA INC., University Health Network
    Inventors: Ralph S. Dacosta, Kathryn Ottolino-Perry, Christopher Gibson, Nayana Thalanki Anantha, Simon Treadwell, Todd Daynes, Todd Meaney, Garrett Vermey, Carl Annis
  • Patent number: 12299908
    Abstract: The present disclosure provides methods, systems, and devices for coregistering imaging data to form three-dimensional superimposed images of target such as a tumor or a surgical bed. A three-dimensional map can be generated by projecting infrared radiation at a target area, receiving reflected infrared radiation, and measuring depth of the target area. A three-dimensional white light image can be created from a captured two-dimensional white light image and the three-dimensional map. A three-dimensional fluorescence image can be created from a captured two-dimensional fluorescence image and the three-dimensional map. The three-dimensional white light image and the three-dimensional fluorescence image can be aligned using one or more fiducial markers to form a three-dimensional superimposed image. The superimposed image can be used to excise cancerous tissues, for example, breast tumors. Images can be in the form of videos.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: May 13, 2025
    Assignee: University Health Network
    Inventors: Ralph S. Dacosta, Kathryn Ottolino-Perry, Christopher Gibson
  • Publication number: 20220248944
    Abstract: An endoscopic imaging device is disclosed. The device includes a body portion configured to be held in a user's hand and an endoscope portion configured to direct light onto a target. At least one excitation light source is configured to excite autofluorescence emissions of tissue cells and fluorescence emissions of induced porphyrins in tissue cells of the target. A white light source is configured to illuminate the surgical margin during white light imaging of the target. The device also includes an imaging sensor and a first optical filter configured to filter optical signals emitted by the target responsive to illumination with excitation light and permit passage of autofluorescence emissions of tissue cells and fluorescence emissions of the induced porphyrins in tissue cells to the imaging sensor.
    Type: Application
    Filed: January 17, 2020
    Publication date: August 11, 2022
    Applicants: University Health Network, SBI ALAPHARMA CANADA INC.
    Inventors: Ralph S. DACOSTA, Kathryn OTTOLINO-PERRY, Christopher GIBSON, Nayana Thalanki ANANTHA, Simon TREADWELL, Todd DAYNES, Todd MEANEY, Garrett VERMEY, Carl ANNIS
  • Publication number: 20220108461
    Abstract: The present disclosure provides methods, systems, and devices for coregistering imaging data to form three-dimensional superimposed images of target such as a tumor or a surgical bed. A three-dimensional map can be generated by projecting infrared radiation at a target area, receiving reflected infrared radiation, and measuring depth of the target area. A three-dimensional white light image can be created from a captured two-dimensional white light image and the three-dimensional map. A three-dimensional fluorescence image can be created from a captured two-dimensional fluorescence image and the three-dimensional map. The three-dimensional white light image and the three-dimensional fluorescence image can be aligned using one or more fiducial markers to form a three-dimensional superimposed image. The superimposed image can be used to excise cancerous tissues, for example, breast tumors. Images can be in the form of videos.
    Type: Application
    Filed: January 17, 2020
    Publication date: April 7, 2022
    Applicant: University Health Network
    Inventors: Ralph S. DACOSTA, Kathryn OTTOLINO-PERRY, Christopher GIBSON
  • Publication number: 20220104706
    Abstract: An imaging device includes a body having a first end portion configured to be held in a user's hand and a second end portion configured to direct light onto a surgical margin. The device includes at least one excitation light source configured to excite autofluorescence emissions of tissue cells and fluorescence emissions of induced porphyrins in tissue cells of the surgical margin. A white light source is configured to illuminate the surgical margin during white light imaging of the surgical margin. The device includes an imaging sensor, a first optical filter configured to permit passage of autofluorescence emissions of tissue cells and fluorescence emissions of the induced porphyrins in tissue cells to the imaging sensor, and a second optical filter configured to permit passage of white light emissions of tissues in the surgical margin to the imaging sensor. Systems and methods relate to imaging devices.
    Type: Application
    Filed: January 17, 2020
    Publication date: April 7, 2022
    Applicants: SBI ALAPHARMA CANADA INC., University Health Network
    Inventors: Ralph S. DACOSTA, Kathryn OTTOLINO-PERRY, Christopher GIBSON, Nayana Thalanki ANANTHA, Simon TREADWELL, Todd DAYNES, Todd MEANEY, Garret VERMEY, Carl ANNIS
  • Publication number: 20220082500
    Abstract: A tissue phantom is disclosed. The tissue phantom includes a first portion having the optical properties of healthy tissue and a second portion having the optical properties of cancerous tissue. Additionally, a method of calibrating an optical instrument is disclosed. The method includes illuminating a tissue phantom with excitation light from the optical instrument, detecting optical emissions emitted by the tissue phantom in response to illumination with the excitation light, and calibrating the optical instrument based upon the detected fluorescence.
    Type: Application
    Filed: January 17, 2020
    Publication date: March 17, 2022
    Applicant: University Health Network
    Inventors: Ralph S. DACOSTA, Kathryn OTTOLINO-PERRY, Christopher GIBSON, Nayana Thalanki ANANTHA, Cristiana O'BRIEN
  • Publication number: 20200367818
    Abstract: A method of assessing surgical margins is disclosed. The method includes, subsequent to administration of a compound configured to induce emissions of between about 600 nm and about 660 nm in cancerous tissue cells, positioning a distal end of a handheld, white light and fluorescence-based imaging device adjacent to a surgical margin. The method also includes, with the handheld device, substantially simultaneously exciting and detecting autofluorescence emissions of tissue cells and fluorescence emissions of the induced wavelength in tissue cells of the surgical margin. And, based on a presence or an amount of fluorescence emissions of the induced wavelength detected in the tissue cells of the surgical margin, determining whether the surgical margin is substantially free of at least one of precancerous cells, cancerous cells, and satellite lesions. The compound may be a non-activated, non-targeted compound such as ALA.
    Type: Application
    Filed: February 1, 2019
    Publication date: November 26, 2020
    Applicant: UNIVERSITY HEALTH NETWORK
    Inventors: Ralph DaCOSTA, Christopher GIBSON, Kathryn OTTOLINO-PERRY, Nayana Thalanki ANANTHA, Susan Jane DONE, Wey-Liang LEONG, Alexandra M. EASSON
  • Patent number: 8250140
    Abstract: An apparatus for enabling connections for use with a network comprising at least one vertex, the apparatus comprising: a receiver, for receiving a first message associated with the first vertex, wherein the first message comprises an indication that the first vertex wishes to join the network; a generator, responsive to receipt of the first message, for generating a second message associated with the at least one vertex, wherein the second message comprising an indication that the at least one vertex is operable to connect to the first vertex; and a probabilistic component for determining a first time value associated with transmission of the second message to the first vertex in accordance with probabilistic data.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: August 21, 2012
    Assignee: International Business Machines Corporation
    Inventors: Graham A Bent, Flavio A Bergamaschi, Patrick Dantressangle, Christopher Gibson
  • Publication number: 20090083379
    Abstract: An apparatus for enabling connections for use with a network comprising at least one vertex, the apparatus comprising: a receiver, for receiving a first message associated with the first vertex, wherein the first message comprises an indication that the first vertex wishes to join the network; a generator, responsive to receipt of the first message, for generating a second message associated with the at least one vertex, wherein the second message comprising an indication that the at least one vertex is operable to connect to the first vertex; and a probabilistic component for determining a first time value associated with transmission of the second message to the first vertex in accordance with probabilistic data.
    Type: Application
    Filed: April 11, 2008
    Publication date: March 26, 2009
    Inventors: Graham A Bent, Flavio A Bergamaschi, Patrick Dantressangle, Christopher Gibson
  • Publication number: 20050257128
    Abstract: A network client such as a WWW browser configured to facilitate a windowed content manifestation environment (CME) which is configured to operate within a data processing system and to receive content from a remote server system to facilitate a windowed content manifestation environment. In particular, the customized WWW browser application includes a content retrieval module configured to receive content from a network server system via an electronic data network, and a processing engine coupled to the content retrieval module. The processing engine is configured to provide a content manifestation environment within the data processing system, and to process the content to produce at least one corresponding window object within the content manifestation environment. The corresponding window object(s) are configured to manifest at least a portion of the content therein.
    Type: Application
    Filed: July 26, 2005
    Publication date: November 17, 2005
    Inventors: Sandro Pasquali, Christopher Gibson
  • Patent number: D908881
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: January 26, 2021
    Assignees: SBI ALAPHARMA CANADA, INC., UNIVERSITY HEALTH NETWORK
    Inventors: Ralph S. Dacosta, Kathryn Ottolino-Perry, Christopher Gibson, Nayana Thalanki Anantha, Simon Treadwell, Todd Daynes, Todd Meaney
  • Patent number: D910182
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: February 9, 2021
    Assignees: SBI ALAPHARMA CANADA, INC., UNIVERSITY HEALTH NETWORK
    Inventors: Ralph S. Dacosta, Kathryn Ottolino-Perry, Christopher Gibson, Nayana Thalanki Anantha, Simon Treadwell, Connor Wright, Kimberlyn Dampitan, Todd Daynes, Todd Meaney
  • Patent number: D958991
    Type: Grant
    Filed: January 26, 2021
    Date of Patent: July 26, 2022
    Assignees: SBI ALAPHARMA CANADA, INC., UNIVERSITY HEALTH NETWORK
    Inventors: Ralph S. Dacosta, Kathryn Ottolino-Perry, Christopher Gibson, Nayana Thalanki Anantha, Simon Treadwell, Connor Wright, Kimberlyn Dampitan, Todd Daynes, Todd Meaney
  • Patent number: D959666
    Type: Grant
    Filed: January 22, 2021
    Date of Patent: August 2, 2022
    Assignees: SBI ALAPHARMA CANADA, INC., UNIVERSITY HEALTH NETWORK
    Inventors: Ralph S. Dacosta, Kathryn Ottolino-Perry, Christopher Gibson, Nayana Thalanki Anantha, Simon Treadwell, Todd Daynes, Todd Meaney
  • Patent number: D1017040
    Type: Grant
    Filed: June 10, 2022
    Date of Patent: March 5, 2024
    Assignees: SBI ALAPHARMA CANADA, INC., University Health Network
    Inventors: Ralph S. Dacosta, Kathryn Ottolino-Perry, Christopher Gibson, Nayana Thalanki Anantha, Simon Treadwell, Todd Daynes, Todd Meaney
  • Patent number: D1031990
    Type: Grant
    Filed: June 14, 2022
    Date of Patent: June 18, 2024
    Assignee: SBI ALAPHARMA CANADA, INC.
    Inventors: Ralph S. Dacosta, Kathryn Ottolino-Perry, Christopher Gibson, Nayana Thalanki Anantha, Simon Treadwell, Connor Wright, Kimberlyn Dampitan, Todd Daynes, Todd Meaney